Stahl Neil 的 Form 4 申報
Regeneron Pharmaceuticals, Inc.（REGN），2024/8/12 申報
- 申報編號
- 0001968202-24-000115
- 申報時間
- 2024/8/12
- 交易日
- 2024/8/8-8/12
- 申報延遲
- 4 天
- 10b5-1 計畫
- 有勾選
這份申報列了 7 筆非衍生性交易。公開市場賣出合計 $563.6 萬。交易後 4 天申報。
申報人
一份 Form 4 可以有好幾位申報人，例如本人與他控制的基金。各交易表上顯示的是第一位。
| 申報人 | 與公司的關係 |
|---|---|
| Stahl NeilCIK 0001226689 | 高階主管（EVP Research and Development） |
非衍生性證券（表 I）
普通股等股票的取得與處分，每一列是申報上的一筆。
| 交易日 | 證券 | 交易 | 股數 | 價格 | 金額 | 交易後持股 | 持有方式 | 旗標 |
|---|---|---|---|---|---|---|---|---|
| 2024/8/8 | Common Stock | S賣出處分 | −100 | $1,081.83F1 | −$108,183 | 56,096 | 直接 | |
| 2024/8/8 | Common Stock | S賣出處分 | −200 | $1,082.69F2 | −$216,538 | 55,896 | 直接 | |
| 2024/8/8 | Common Stock | S賣出處分 | −1,006 | $1,083.76F3 | −$1,090,262.56 | 54,890 | 直接 | |
| 2024/8/8 | Common Stock | S賣出處分 | −1,883 | $1,084.61F4 | −$2,042,320.63 | 53,007 | 直接 | |
| 2024/8/8 | Common Stock | S賣出處分 | −1,708 | $1,085.01F5 | −$1,853,197.08 | 51,299 | 直接 | |
| 2024/8/8 | Common Stock | S賣出處分 | −300 | $1,086.15F6 | −$325,845 | 50,999 | 直接 | |
| 2024/8/12 | Common Stock | G贈與處分 | −900 | $0.00 | $0 | 50,099 | 直接 |
附註與備註
本站收錄交易價格引用的附註、修正申報（Form 4/A）的全部附註，以及申報的備註。其他附註，例如間接持有的方式、交易計畫的細節，請看 SEC EDGAR 上的原文。
- F1
Represents volume-weighted average price of sales of 100 shares of Company stock on August 8, 2024 at prices ranging from $1,081.75 to $1,081.91. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F2
Represents volume-weighted average price of sales of 200 shares of Company stock on August 8, 2024 at prices ranging from $1,082.65 to $1,082.74. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F3
Represents volume-weighted average price of sales of 1,006 shares of Company stock on August 8, 2024 at prices ranging from $1,083.27 to $1,083.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F4
Represents volume-weighted average price of sales of 1,883 shares of Company stock on August 8, 2024 at prices ranging from $1,084.01 to $1,084.99. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F5
Represents volume-weighted average price of sales of 1,708 shares of Company stock on August 8, 2024 at prices ranging from $1,085.00 to $1,085.79. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。
- F6
Represents volume-weighted average price of sales of 300 shares of Company stock on August 8, 2024 at prices ranging from $1,086.14 to $1,086.16. Upon request by the Commission staff, the Company, or a security holder of the Company, the reporting person will provide full information regarding the number of shares sold by the reporting person on August 8, 2024 at each separate price.
表 I 有 1 筆交易的價格引用這則附註。